Amanda Barrell, Author at

While proponents argue waiving IP on COVID-19 vaccines would better enable low- and middle-income countries to inoculate their

IP is no barrier to COVID vaccine access, says industry

https://pharmaphorum.com/market-access-2/ip-is-no-barrier-to-covid-vaccine-access-says-industry/

Patients/ Views & Analysis/ Views and analysis

Representation in UK pharma: A progress report

Amanda Barrell diversity ABPI, ED&I, patients, pharma, UK 0 Comment

Pharma understands that building equitable health services starts with building equitable institutions. But how is the UK’s industry

Representation in UK pharma: A progress report

https://pharmaphorum.com/patients/representation-in-uk-pharma-a-progress-report/

Digital/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Top 5 takeaways from international hybrid and virtual meeting guidance for pharma

Amanda Barrell EFPIA, IFPMA, pharma, PhRMA, remote meetings, virtual meetings 0 Comment

The move to online international meetings has left pharma companies with uncertainty around contact compliance. But new joint

Top 5 takeaways from international hybrid and virtual meeting guidance for pharma

https://pharmaphorum.com/digital/top-5-takeaways-from-international-hybrid-virtual-meeting-guidance/

Location icons of gps navigation, Global 5g high speed internet connection and Big data analysis process background

Digital/ Views & Analysis/ Views and analysis

Joined up thinking needed for joined up data plans

Amanda Barrell data, European Federation of Pharmaceutical Industries and Associations, Health data 0 Comment

Joined up data could transform the pharmaceutical industry and help create a healthier Europe for decades to come

Joined up thinking needed for joined up data plans

https://pharmaphorum.com/digital/joined-up-thinking-needed-for-joined-up-data-plans/

Patients/ Views & Analysis/ Views and analysis

A crisis of trust: How lack of sector confidence is threating patient centricity

Amanda Barrell Novartis, patient centricity, Scott Bradley, trust in pharma 0 Comment

People who trust pharma are more interested in using the industry’s services – making building confidence in the

A crisis of trust: How lack of sector confidence is threating patient centricity

https://pharmaphorum.com/patients/a-crisis-of-trust-how-lack-of-sector-confidence-is-threating-patient-centricity/

Patients/ Views & Analysis/ Views and analysis

Engagement to partnership: The changing face of patient involvement

Amanda Barrell Iris Loew-Friedrich, patient engagement, UCB 0 Comment

The era of patient engagement is over. Instead, it’s time to move towards true partnership at every step

Engagement to partnership: The changing face of patient involvement

https://pharmaphorum.com/patients/engagement-to-partnership-changing-face-patient-involvement/

Patients/ Sales and Marketing/ Views & Analysis/ Views & Analysis/ Views and analysis

Independent health comms agencies rebrand with emphasis on authenticity

Amanda Barrell healthcare communications, patient engagement, pharma 0 Comment

In a world of a million messages, should authenticity be the common thread tying all pharma communications and

Independent health comms agencies rebrand with emphasis on authenticity

https://pharmaphorum.com/views-analysis-patients/independent-health-comms-agencies-rebrand-with-emphasis-on-authenticity/

Market Access/ Views & Analysis/ Views and analysis

What is the solution to America’s deepening access to medicines crisis?

Amanda Barrell America, insulin, Joe Biden, Pharmaceutical Research and Manufacturers of America 0 Comment

Last week, a bill to limit the cost of insulin in the US passed the House of Representatives,

What is the solution to America’s deepening access to medicines crisis?

https://pharmaphorum.com/market-access-2/what-is-the-solution-to-americas-deepening-access-to-medicines-crisis/

healthcare professionals digital communications

Sales and Marketing/ Views & Analysis/ Views and analysis

Measuring success in pharma marketing: Does engagement equate to prescriptions?

Amanda Barrell digital engagement, HCPs, pharma marketing, prescriptions 0 Comment

Is engagement the equivalent of a “digital smile” in pharma marketing, or have we been measuring communications efficacy

Measuring success in pharma marketing: Does engagement equate to prescriptions?

https://pharmaphorum.com/sales-marketing/measuring-success-in-pharma-marketing-does-engagement-equate-to-prescriptions/

Trending

About Amanda Barrell

Posts by Amanda Barrell:

IP is no barrier to COVID vaccine access, says industry

Representation in UK pharma: A progress report

Top 5 takeaways from international hybrid and virtual meeting guidance for pharma

Joined up thinking needed for joined up data plans

A crisis of trust: How lack of sector confidence is threating patient centricity

Engagement to partnership: The changing face of patient involvement

Independent health comms agencies rebrand with emphasis on authenticity

What is the solution to America’s deepening access to medicines crisis?

Measuring success in pharma marketing: Does engagement equate to prescriptions?

Trending

About Amanda Barrell

Posts by Amanda Barrell:

Login